{"id":543,"date":"2022-11-18T19:21:15","date_gmt":"2022-11-18T19:21:15","guid":{"rendered":"https:\/\/www.biosyent.com\/?post_type=pressrelease&p=543"},"modified":"2022-11-18T19:21:15","modified_gmt":"2022-11-18T19:21:15","slug":"biosyent-releases-q4-and-full-year-2014-results-full-year-sales-up-57-pharma-sales-up-63-net-income-up-64-diluted-eps-0-22-up-69-cash-and-short-term-investments-8-0-million-up-82","status":"publish","type":"pressrelease","link":"https:\/\/www.biosyent.com\/fr\/pressrelease\/biosyent-releases-q4-and-full-year-2014-results-full-year-sales-up-57-pharma-sales-up-63-net-income-up-64-diluted-eps-0-22-up-69-cash-and-short-term-investments-8-0-million-up-82\/","title":{"rendered":"BioSyent Releases Q4 And Full Year 2014 Results \u2013 Full Year Sales Up 57%; Pharma Sales Up 63%; Net Income Up 64%; Diluted Eps $0.22 Up 69%; Cash And Short-term Investments $8.0 Million Up 82%"},"excerpt":{"rendered":"","protected":false},"template":"","class_list":["post-543","pressrelease","type-pressrelease","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/pressrelease\/543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/pressrelease"}],"about":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/types\/pressrelease"}],"wp:attachment":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/media?parent=543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}